4.7 Article

In Vivo Actions of Peroxisome Proliferator-Activated Receptors Glycemic control, insulin sensitivity, and insulin secretion

Journal

DIABETES CARE
Volume 36, Issue -, Pages S162-S174

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dcS13-2003

Keywords

-

Funding

  1. Abbott
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Bristol-Myers Squibb
  5. Eli Lilly
  6. Ethicon Endo-Surgery
  7. Janssen
  8. Medtronic
  9. Novo Nordisk
  10. Sanofi
  11. Takeda

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available